Critical Innovations

What Critical Innovations does

Critical Innovations LLC is a privately held medical device research and development company founded in 2012 and headquartered in Lawndale, California, with a Los Angeles prototyping and manufacturing facility. The company develops investigational medical technologies for trauma care, emergency medicine, and combat casualty care, with a portfolio of more than ten proprietary platforms including the Revite automated extracorporeal life support (ECLS) resuscitation system, the F.O.A.M. thermoreversible intra-abdominal foam for noncompressible torso hemorrhage, the Succor combat foam family (burn, penetrating trauma, sulfur mustard injuries), the BurRapid intracranial access platform, the Eye-Aid ocular injury system, and additive-manufactured surgical instruments under the SurgNow brand. All products are currently labeled investigational and are not FDA-cleared for commercial sale.

The business model is almost entirely government-contract-based: Critical Innovations has executed more than 50 Department of Defense awards spanning SBIR Phase I, Phase II, Phase IIE, Sequential Phase II, and Direct-to-Phase II awards, plus Other Transaction Agreements with military branches (U.S. Army, Navy, Air Force, Space Force) and agencies including DARPA, the Defense Health Agency, USAMMDA, USAMRDC, the Office of Naval Research, and the Chemical and Biological Defense Program. Reported commercialization leverage is $1.63 in Phase III follow-on funding per Phase II SBIR dollar — roughly six times the $0.26 industry average tracked by GAO/SBA — alongside a 99.5% on-time program deliverable rate as prime contractor.

The company serves primarily U.S. military and defense end users (combat medics, far-forward casualty care, prolonged field care) with a secondary civilian emergency medicine vertical. Commercial sales are contingent on FDA clearance of the investigational pipeline. The firm is FDA-registered, ISO 13485:2016 certified by the National Standards Authority of Ireland, compliant with 21 CFR Part 820 QMSR and DCAA, and holds a California Medical Device Manufacturing License. It is led by Dr. Ross I. Donaldson as President & CEO and operates with a 1–10 person core team supplemented by clinical, engineering, and quality specialists. No institutional equity capital has been disclosed; funding is contract-based non-dilutive government R&D.

Name

Critical Innovations

Legal name

Critical Innovations LLC

Website

https://criticalinnovations.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

Critical Innovations LLC is a privately held DoD contractor developing investigational medical devices for trauma and combat casualty care, including automated resuscitation systems, hemostatic foams, and battlefield surgical instruments, funded primarily through SBIR awards and Other Transaction Agreements.

Ownership category

akta.pro rank

Headquarters

HQ city

Lawndale

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Federal R&D Contracts and SBIR Awards: The company generates revenue through Small Business Innovation Research (SBIR) Phase I, Phase II, and Phase IIE awards, as well as Other Transaction Agreements with military agencies. Additional revenue comes from Joint Warfighter Medical Research Program awards, Congressionally Directed Medical Research Programs, and direct contracts from military branches. The company has achieved $1.63 in Phase III follow-on for every Phase II SBIR dollar invested.
2. Product Commercialization (Future): Critical Innovations is developing multiple medical technologies toward regulatory clearance. All current products are listed as INVESTIGATIONAL and NOT AVAILABLE FOR COMMERCIAL SALE. Future revenue anticipated from FDA-cleared medical devices for military and civilian trauma care markets.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Critical Innovations is a medical device research and development company developing investigational trauma care, emergency medicine, and combat casualty care technologies for pre-hospital, hospital, and military environments. Its portfolio spans automated extracorporeal resuscitation, thermoreversible hemostatic foams, intracranial access, ocular trauma, needle decompression, thoracostomy, wearable e-textiles, on-demand surgical instruments, and a manufacturing qualification system, all funded primarily through U.S. Department of Defense SBIR awards and Other Transaction Agreements. Products are not yet FDA-cleared and not available for commercial sale.

Product overview

Critical Innovations is a medical device research and development company developing multiple trauma care technologies for military and emergency medicine applications. The portfolio consists of physical medical devices and therapeutic products—not a unified software platform. Key products include: the Revite™ Automated Trauma Resuscitation System (ECLS-based trauma resuscitation under DARPA GOLDEVAC); F.O.A.M.™ (Fast Onset Abdominal Management - thermoreversible intra-abdominal foam for noncompressible hemorrhage, MTEC 2020 Prototype of the Year); the Succor™ Combat Foam family (multiple variants for burn wounds, traumatized tissue, penetrating trauma, and sulfur mustard injuries); BurRapid™ Intracranial Access Platform (TBI monitoring/intervention); Eye-Aid™ System (ocular injuries); Donaldson Decompression Needle™; PleuraPath™ Thoracostomy System; Aid-Tex™ Wearable e-Textile System; Rx-Shooter™ Wound Infection Treatment Device; SurgNow™ On-Demand Surgical Instruments; and Fully-Qualified Manufacturing™ (FQM™). All products are investigational and not FDA-cleared for human use.

Differentiator

Problem solved

Functional benefit

Brands

• F.O.A.M.™: Fast Onset Abdominal Management - a thermoreversible intra-abdominal foam for treating noncompressible torso hemorrhage (NCTH). MTEC 2020 Prototype of the Year Award recipient.
• Revite™
• Succor™
• Eye-Aid™
• BurRapid™
• Donaldson Decompression Needle™
• Aid-Tex™
• PleuraPath™
• Rx-Shooter™
• SurgNow™
• Fully-Qualified Manufacturing™ (FQM™)

Products and services

• Aid-Tex™ Wearable e-Textile System A wearable electronic textile system developed under DHA SBIR funding for advanced textile-based medical monitoring and intervention capabilities, intended for military and pre-hospital use.
• BurRapid™ Intracranial Access Platform Intracranial access and pressure monitoring platform designed for far-forward traumatic brain injury intervention in military settings, including an intracranial pressure monitor attachment.
• Donaldson Decompression Needle™ Needle decompression device developed for emergency needle thoracostomy procedures in trauma care, with funding from the Defense Health Agency.
• Eye-Aid™ System for Acute Ocular Injuries System for acute ocular injuries designed to treat penetrating globe trauma, funded through an Other Transaction Agreement with the U.S. Army Medical Materiel Development Activity.
• Fast Onset Abdominal Management™ (F.O.A.M.™) Thermoreversible intra-abdominal foam that deploys a rapidly expanding foaming agent from a prefilled pressurized canister via an autostopping needle inserted into the peritoneal cavity to treat noncompressible torso hemorrhage (NCTH).
• Fully-Qualified Manufacturing™ (FQM™) Manufacturing qualification system developed under U.S. Space Force Direct-to-Phase II SBIR funding to advance medical device manufacturing capabilities.
• PleuraPath™ Thoracostomy System Thoracostomy system previously funded under DHA SBIR awards and the FY18 Joint Warfighter Medical Research Program for chest trauma intervention.
• Revite™ Automated Trauma Resuscitation System Simplified, miniaturized, and automated extracorporeal life support (ECLS)-based trauma resuscitation system designed to optimize catheter flow while minimizing cannula size, vascular access requirements, and thrombotic risk. Developed under DARPA's GOLDEVAC program.
• Rx-Shooter™ Wearable Wound Infection Treatment Device Wearable wound infection treatment device developed under DHA Phase I and Phase II SBIR funding.
• Succor™ Combat Foam (Burns / Penetrating Trauma / Traumatized Tissue / Sulfur Mustard Injuries) Foam-forming hydrogel combat foam containing antibiotics (vancomycin and tobramycin) for burn wounds, traumatized tissue, penetrating trauma, and sulfur mustard dermal injuries, with variants for each wound type.
• SurgNow™ On-Demand Surgical Instruments On-demand surgical instruments produced via additive manufacturing for theater medical care, funded through the U.S. Army Medical Research and Development Command (USAMRDC).

Quantifiable outcome

• 99.5% on-time program deliverable achievement rate
• +3 more outcomes

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature11 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Defense Advanced Research Projects Agency (DARPA)coreStrategic or Co-development Partner · 9 April 2025Critical Innovations is developing the Revite Automated Trauma Resuscitation System under DARPA's GOLDen hour extended EVACuation (GOLDEVAC) program. The program aims to expand abilities of automated resuscitation technologies to enable medics to manage complex polytrauma patients from point of injury through evacuation. Critical Innovations is one of three performers in the GOLDEVAC program. Visit led by Lt. Col. Adam Willis, MD, PhD, Program Manager in DARPA's Biological Technologies Office.
• U.S. Army Medical Materiel Development Activity (USAMMDA)coreStrategic or Co-development Partner · 1 July 2024USAMMDA Warfighter Expeditionary Medicine and Treatment (WEMT) Program Management Office partners with Critical Innovations for development of Noncompressible Hemorrhage Control (NHC) and Burn Treatment and Skin Repair (BTSR) technologies. USAMMDA leads development and fielding of FDA-cleared medical devices that fulfill unmet requirements identified by DoD end users.
• Defense Health Agency (DHA)coreStrategic or Co-development PartnerMultiple SBIR awards from DHA for technologies including Aid-Tex Wearable e-Textile System, BurRapid Intracranial Access Platform, Succor Combat Foam, Donaldson Decompression Needle, PleuraPath Thoracostomy System, and Rx-Shooter. Phase I, Phase II, Phase IIE, and Sequential Phase II funding.
• U.S. Army Medical Research and Development Command (USAMRDC)coreStrategic or Co-development PartnerFunding source for SurgNow On-Demand Surgical Instruments through Other Transaction Agreement.
• Military Technology Enterprise Management (MTEC)coreStrategic or Co-development PartnerMTEC 2020 Prototype of the Year Award recipient. F.O.A.M. technology funded by USAMMDA through MTEC.
• Project HOPEminorOthersCritical Innovations assisted Project HOPE to support recovery efforts for California wildfires by providing medical supplies and expertise.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Stryker: Stryker is a large diversified medical device company with a dedicated Emergency and Acute Care portfolio (stretchers, resuscitation, surgical instruments) that competes for DoD and civilian trauma procurement against emerging entrants like Critical Innovations.
• ZOLL Medical: ZOLL Medical (an Asahi Kasei company) is a broad incumbent in resuscitation, defibrillation, and emergency medical devices, competing in trauma and resuscitation categories where Critical Innovations' Revite and other devices will eventually overlap.
• Teleflex: Teleflex offers a broad emergency medicine portfolio including Arrow vascular access, EZ-IO, and rescue airway devices that overlap with several of Critical Innovations' trauma/critical-care indications as a well-established competitor in the same DoD/civilian procurement channels.
• Becton Dickinson (BD): BD is a global medical technology incumbent with a broad surgical, emergency, and trauma product portfolio (including recent acquisitions such as C.R. Bard and Cohera), serving as a prime-contractor competitor for large-scale DoD and civilian medical device procurement.

Direct peers

• North American Rescue: North American Rescue supplies trauma kits, tourniquets, and pre-hospital medical products to military and law enforcement, occupying the same far-forward casualty care procurement channels that Critical Innovations targets with its investigational devices.
• Skedco: Skedco designs and manufactures rescue and casualty evacuation medical equipment (Sked stretcher, HURST tools) used by military medics, paralleling Critical Innovations' focus on medics-in-far-forward-environments tasks and military procurement channels.
• RevMedX: RevMedX develops hemostatic and hemorrhage-control medical devices for combat and pre-hospital use (XStat, FAST bandage), operating as a small government-focused medtech with comparable DoD SBIR-driven model and tactical/civilian trauma overlap.
• Combat Medical Systems: Combat Medical Systems manufactures and distributes hemostatic gauze and tactical medical products (e.g., CELOX) for military and first-responder use, sharing Critical Innovations' combat-casualty-care focus and DoD-aligned customer base.
• Tactical Medical Solutions: Tactical Medical Solutions produces tactical trauma care products including tourniquets, hemostatic dressings, and medic kits for combat medics and law enforcement, overlapping Critical Innovations' pre-hospital and far-forward trauma medical device portfolio.
• Phokus Research: Phokus Research develops and manufactures hemostatic wound care products (e.g., Chitogauze/Rakus) for military and trauma use, with a similar trauma-hemorrhage focus and DoD contracting posture as Critical Innovations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/critical-innovations-llc

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Critical Innovations